Jianming Zhang
7PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 09, 2025
Discovery of Potent and Selective Pyrrolo[2,3-d]pyrimidine Derivatives as Fourth-Generation EGFR Inhibitors Targeting Triple Mutations.Zhenhua Wu, Xueyan Liu, Xiao-E Yan
|Aug 07, 2025
Novel Diaryl-Substituted Pyrazolo[3,4-d]pyrimidines as Tubulin/CDC5L Dual-Targeting Ligands: Discovery, Potent Antitumor Activity, and Good Metabolic Stability.Zhixian Shi, Ruifeng Wang, Haochen Mo
|Jul 24, 2025
Discovery of a Novel MNK Inhibitor (NSP-1047) with In Vivo Anti-acute Myeloid Leukemia Activity.Bing Li, Shuang Xia, Ke Zhang
|Nov 25, 2023
Targeting Esophageal Squamous Cell Carcinoma by Combining Copper Ionophore Disulfiram and JMJD3/UTX Inhibitor GSK J4.Canlin Yang, Fei Li, Yuanyuan Ren
|Jun 13, 2022
Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.Yongyun Li, Jie Yang, Qianqian Zhang
|Nov 30, 2021
A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC.Yue Lu, Zhenzhen Fan, Su-Jie Zhu
Pageof 2
Frequent Collaborators
2 joint publications
Xianming Deng
1 joint publications
Wei Huang
1 joint publications
Fu Gui
1 joint publications
Zheng Wang
1 joint publications
Cai-Hong Yun
1 joint publications
Liang Chen
1 joint publications
Martine J Jager
1 joint publications
Renbing Jia
1 joint publications
Xianqun Fan
1 joint publications
Hexin Yan
